COMP <GO>
BOLT vs LPCN // EV/EBITDA & P/E VALUATION
Bolt Biotherapeutics Inc. (NASDAQ) VS. Lipocine Inc. (NASDAQ) • 15-METRIC TALLY: BOLT 3
— LPCN 1
■ METRIC PARITY
LAST: $6.36 (-3.34%) • MKT CAP: $12.3M
valuation
—
LAST: $1.52 (+0.66%) • MKT CAP: $12.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BOLT VS. LPCN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BOLT | LPCN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 0.10% | -65.00% | +65.10 | BOLT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | BOLT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.2 | 30.9 | +44.29 | BOLT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.3M | $12.5M | -$279.7K | LPCN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BOLT REV | LPCN REV | BOLT GROSS % | LPCN GROSS % | BOLT FCF | LPCN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.7M | $2.0M | — | — | -$39.9M | -$9.8M |
| FY 2024 | $7.7M | $11.2M | — | — | -$61.3M | -$1.3M |
| FY 2023 | $7.9M | -$2.9M | — | — | -$69.5M | -$11.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BOLT // BETA —
LPCN // BETA —